Clonally unrelated primary large B-cell lymphomas separated by over a decade involving the central nervous system and testicle: Possible predisposition to lymphomas of immune-privileged sites?

被引:0
|
作者
George, Giby V. [1 ]
Aldowitz, Diana G. [1 ]
Jajosky, Audrey N. [1 ]
Wallace, Danielle S. [2 ]
Burack, W. Richard [1 ]
Friedberg, Jonathan W. [2 ]
El Hussein, Siba [3 ]
机构
[1] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester 14627, NY USA
[2] Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY USA
[3] Univ Vermont, Larner Coll Med, Dept Pathol, Burlington, VT 05403 USA
来源
EJHAEM | 2024年 / 5卷 / 03期
关键词
clonality; primary large B-cell lymphomas of immune-privileged sites; RELAPSE; FEATURES;
D O I
10.1002/jha2.898
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary large B-cell lymphomas of immune-privileged sites (IP-LBCLs) comprise LBCLs arising within "immune sanctuaries," including the central nervous system (CNS), vitreoretina, and testes. Although patients present with localized disease, the prognosis remains poor with high relapse rates, either at the originating site or within another immune-privileged site. Generally, in the presence of an antecedent IP-LBCL, subsequent LBCLs are expected to be clonally related. However, we present a primary CNS LBCL and later primary testicular LBCL in a middle-aged man, diagnosed over a decade apart, which proved to be clonally unrelated by targeted ultra-deep next-generation sequencing of the IgH locus.
引用
收藏
页码:599 / 602
页数:4
相关论文
共 50 条
  • [41] Outcomes of Autologous Stem Cell Transplantation as a Consolidative Strategy for the Treatment of Primary and Isolated Secondary Central Nervous System Diffuse Large B Cell Lymphomas
    Sahin, Ugur
    Gokmen, Ayla
    Soydan, Ender
    Urlu, Selin M.
    Merter, Mustafa
    Gokgoz, Zafer
    Arslan, Onder
    Ozcan, Muhit
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (01): : E1 - E13
  • [42] The Expression of Progenitor Cell Markers in Primary Central Nervous System Lymphoma: Role of SOX2/OCT4 in Lymphomas with B-Cell Phenotype
    Niflioglu, G. Gul
    Pekmezci, M.
    Krasik, E. F.
    Tihan, T.
    MODERN PATHOLOGY, 2013, 26 : 416A - 416A
  • [43] The Expression of Progenitor Cell Markers in Primary Central Nervous System Lymphoma: Role of SOX2/OCT4 in Lymphomas with B-Cell Phenotype
    Niflioglu, G. Gul
    Pekmezci, M.
    Krasik, E. F.
    Tihan, T.
    LABORATORY INVESTIGATION, 2013, 93 : 416A - 416A
  • [44] Low grade b-cell non-Hodgkin lymphomas (NHL) involving the central nervous system (CNS): An analysis from the National Cancer Database (NCDB).
    Pophali, Priyanka Avinash
    Thanarajasingam, Gita
    Pulido, Jose
    Johnston, Patrick B.
    Go, Ronald S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Immunohistochemical analysis of cleaved caspase-3 detects high level of apoptosis frequently in diffuse large B-cell lymphomas of the central nervous system
    Arai, M
    Sasaki, A
    Saito, N
    Nakazato, Y
    PATHOLOGY INTERNATIONAL, 2005, 55 (03) : 122 - 129
  • [46] The possible benefit from total tumour resection in primary diffuse large B-cell lymphoma of central nervous system - a one-decade single-centre experience
    Jelicic, Jelena
    Balint, Milena Todorovic
    Raicevic, Sava
    Ilic, Rosanda
    Stanisavljevic, Dejana
    Bila, Jelena
    Antic, Darko
    Balint, Bela
    Andjelic, Bosko
    Djurasinovic, Vladislava
    Sretenovic, Aleksandra
    Vukovic, Vojin
    Mihaljevic, Biljana
    BRITISH JOURNAL OF NEUROSURGERY, 2016, 30 (01) : 80 - 85
  • [47] Postranslationally Modified Proteins in the Central Nervous System (CNS) Are the Dominant Antigenic Target/Stimulus of the B-Cell Receptor (BCR) in Primary CNS Lymphomas (PCNSL) Providing Strong Evidence for the Role of Chronic Autoantigenic Stimulation As an Early Step in the Pathogenesis of Aggressive B-Cell Lymphomas
    Thurner, Lorenz
    Kemele, Maria
    Fadle, Natalie
    Regitz, Evi
    Roth, Patrick
    Weller, Michael
    Szczepanowski, Monika
    Klapper, Wolfram
    Monoranu, Camelia-Maria
    Rosenwald, Andreas
    Buslei, Rolf
    Bohle, Rainer Maria
    Kim, Yoo-Jin
    Preuss, Klaus-Dieter
    Pfreundschuh, Michael
    BLOOD, 2014, 124 (21)
  • [48] Systemic diffuse large B-cell lymphoma involving the central nervous system has high rates of defective antigen presentation and immune surveillance
    Wight, Joel
    Blombery, Piers
    Lickiss, Jennifer
    Burgess, Melinda
    Gould, Clare
    Minson, Adrian
    Swain, Fiona
    Sabdia, Muhammed B.
    Gandhi, Maher K.
    Birchley, Andrew
    Keane, Colm
    Hawkes, Eliza A.
    HAEMATOLOGICA, 2024, 109 (09) : 3013 - 3018
  • [49] MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas
    Nayyar, Naema
    White, Michael D.
    Gill, Corey M.
    Lastrapes, Matthew
    Bertalan, Mia
    Kaplan, Alexander
    D'Andrea, Megan R.
    Bihun, Ivanna
    Kaneb, Andrew
    Dietrich, Jorg
    Ferry, Judith A.
    Martinez-Lage, Maria
    Giobbie-Hurder, Anita
    Borger, Darrell R.
    Rodriguez, Fausto J.
    Frosch, Matthew P.
    Batchelor, Emily
    Hoang, Kaitlin
    Kuter, Benjamin
    Fortin, Sarah
    Holdhoff, Matthias
    Cahill, Daniel P.
    Carter, Scott
    Brastianos, Priscilla K.
    Batchelor, Tracy T.
    BLOOD ADVANCES, 2019, 3 (03) : 375 - 383
  • [50] Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart
    Chang, Chen
    Lin, Ching-Hung
    Cheng, Ann-Lii
    Medeiros, L. Jeffrey
    Chang, Kung-Chao
    HISTOPATHOLOGY, 2015, 67 (05) : 625 - 635